Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy

Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy

After neoadjuvant chemoradiotherapy (NCRT) in locally advanced esophageal squamous cell cancer (ESCC), roughly 40% of the patients may achieve pathologic complete response (pCR). Those patients may benefit from organ-saving strategy if the probability of pCR could be correctly identified before esop...

Full description

Bibliographic Details
Main Authors: Yue Li, Jun Liu, Hong-xuan Li, Xu-wei Cai, Zhi-gang Li, Xiao-dan Ye, Hao-hua Teng, Xiao-long Fu, Wen Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant chemoradiation
esophageal cancer
response prediction
organ-saving treatment
radiomics
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.615167/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.615167/full

Similar Items